sglt2 semaglutide inhibitor once weekly as add-on to SGLT-2 therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial Effect of combination treatment with – The Future of Type 2

Our team finds that adding 2 mL is a great all-purpose choice, providing a concentration that is easy to measure for a wide range of doses

Researchers gave participants either a placebo or 1,000 mcg of vitamin B12 daily for eight weeks

Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial

Beach and tropical vacations Heat is the primary enemy in tropical climates

1 a In a phase 1 clinical study conducted with PF-06882961, the half-life and the area under the plasma drug concentration-time curve did not differ between the fed and fasted states

J Clin Endocrinol Metab 2019